Ann: Notification regarding unquoted securities - BOT, page-55

Cool. If you've read any of my posts around this suggestion (of a potential buyout) I have always suggested it would have a $ in front of it. I don't think anybody who has considered a similar proposition on here has imagined a buyout without a $ sign. Personally I don't correlate what the market is currently thinking of BOT (at 17-18c) to be accurate and I think any potential buyer knows that. For me the clincher is irrespective of the SP, Matt & co won't sell BOT unless it's in the realm of what they know it to be worth (and that always starts with a $ sign, IMO). As a buyer who sees value in BOT you have a choice - offer SP value and not be able to buy it, or offer what it's really worth and maybe BOT will sell. That's why I think a significant jump in SP to what's currently on offer is not a fantasy and could easily be revealed upon the first TH following FDA approval.

Then again, I may just have to wait until BOT demonstrate actual sales.